CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Growing awareness and adoption of preventive healthcare
4.1.2. Rapid growth in the geriatric population and high incidences of renal disorders
4.1.3. Increasing number of drug development initiatives
4.1.4. Rising incidence of other chronic disorders impacting renal function
4.1.5. Favourable government initiatives to promote renal health
4.2. Market Restraints & Challenges
4.2.1. Repeatedly changing regulatory policies
4.2.2. Identification of novel renal dysfunction biomarkers
4.3. Market Opportunities
4.3.1. Commercialization of advanced testing methods
4.3.2. High growth potential in emerging countries
CHAPTER 5. GLOBAL CREATININE MEASUREMENT MARKET – BY PRODUCT
5.1. Reagents
5.2. Kits
CHAPTER 6. GLOBAL CREATININE MEASUREMENT MARKET – BY TYPE
6.1. Enzymatic method
6.2. Jaffe’s kinetic method
CHAPTER 7. GLOBAL CREATININE MEASUREMENT MARKET – BY SAMPLE
TYPE
7.1. Urine
7.2. Blood/Serum
CHAPTER 8. GLOBAL CREATININE MEASUREMENT MARKET – BY END USER
8.1. Diagnostics laboratories
8.2. Hospitals
CHAPTER 9. GLOBAL CREATININE MEASUREMENT MARKET - BY
GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10. GLOBAL CREATININE MEASUREMENT MARKET - COMPANY
PROFILES
10.1. Ortho Clinical Diagnostics
10.2. Diazyme Laboratories, Inc
10.3. Dialab GmbH
10.4. Sentinel Ch. SPA
10.5. Diasys Diagnostic Systems GmbH
10.6. Siemens Healthineers (A Division of Siemens AG)
10.7. F. Hoffmann-La Roche AG
10.8. Abbott Laboratories
10.9. Danaher Corporation (Beckman Coulter)
10.10 Thermo Fisher Scientific Inc.
10.11. Randox Laboratories
10.12. Wako Pure Chemical Industries, Ltd
10.13. Pointe Scientific, Inc (A Part of Medtest Holdings)
10.14. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
CHAPTER 11. GLOBAL CREATININE MEASUREMENT MARKET - COMPETITIVE
LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12. MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13. APPENDIX
13.1. List of Tables
13.2. List of Figures
